Gilead, Foresite Take Pardes Biosciences Public In $250M SPAC Deal
Pardes Biosciences Inc, an early-stage biopharmaceutical company, and FS Development Corp. II (NASDAQ:FSII), a Foresite Capital sponsored SPAC, entered into a…
What’s Next For Indie Semiconductors Stock After SPAC Deal?
Indie Semiconductors Inc. (NASDAQ: INDI) shares are trading higher Tuesday morning after the company was listed on the Nasdaq schange.
Digital Advertising Company System1 Gets SPAC Deal With Bill Foley: What Investors Should Know
A leading omnichannel customer acquisition platform announced a SPAC deal Tuesday with a well-known SPAC sponsor.
SoftBank-Backed Dingdong Downsizes U.S. IPO Target Following Missfresh Debacle: Reuters
SoftBank Group Corp (OTC:SFTBY) (OTC:SFTBF) Vision Fund II backed Chinese grocery app, Dingdong has downsized its U.S. initial public…
System1 To Go Public Through Merger With Trebia Acquisition Corp.; Co. Will Be Valued At $1.4B
System1, a fast-growing and profitable omnichannel customer acquisition platform, will be valued at $1.4 billion in connection with the transaction.
The growth capital provided by the transaction will
Warehouse Robotics Company AutoStore Targets $10B IPO: Bloomberg
Norwegian warehouse robotics company, AutoStore, is exploring an initial public offering that could value it over $10 billion, Bloomberg…
Pardes Biosciences To Go Public Through Merger With FS Development Corp. II; Total Proceeds From Transaction Expected To Be $276M
Leading institutional and strategic investors commit $75 million through a common stock private investment in public equity ("PIPE") led by Foresite Capital, as well as Gilead Sciences, RA
Didi Global Expected to Price IPO at Top of Range of $13 to $14/Share or Above
-Reuters
https://www.reuters.com/business/didi-flags-ipo-share-price-top-range-or-above-source-2021-06-29/